Drug Profile
Chlorpheniramine/hydrocodone/pseudoephedrine
Alternative Names: Chlorpheniramine/hydrocodone/pseudoephedrine - Currax Pharmaceuticals; Chlorpheniramine/pseudoephedrine/hydrocodone; Hydrocodone/chlorpheniramine/pseudoephedrine; Hydrocodone/pseudoephedrine/chlorpheniramine; Pseudoephedrine/chlorpheniramine/hydrocodone; Pseudoephedrine/hydrocodone/chlorpheniramine; ZUTRIPROLatest Information Update: 09 May 2019
Price :
$50
*
At a glance
- Originator Cypress Pharmaceutical
- Developer Currax Pharmaceuticals
- Class Antihistamines; Antitussives; Decongestants; Morphinans; Opioid analgesics; Opioid peptides; Propanolamines; Small molecules
- Mechanism of Action Alpha adrenergic receptor agonists; Histamine H1 receptor antagonists; Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Common cold; Cough; Nasal congestion